avid has been involved as a research scientist, manager and leader of drug
discovery programs, and advisor and investor in life sciences companies since 1985. Trained as a molecular biologist, he was at Genentech (NYSE:DNA) for 16 years, and was Director of Cardiovascular Research there from 1993 to 1999. At Genentech, David led drug discovery activities in biologics and small molecule therapeutics. He was responsible for drug discovery efforts that resulted in eight drug candidates taken into clinical development, including the successful cancer therapy Avastin™. David was a member of the therapeutic area team responsible for cardiovascular strategic planning and product portfolio management, and worked extensively with Business Development on in-licensing of early and late-stage therapeutics, and technology access. David holds BS and PhD degrees in biochemistry from the University of Toronto, Canada. He has authored over 60 peer-reviewed scientific publications and is an inventor on 7 issued or pending US patents. He joined Skyline in 2002 as a Kauffman Fellow, and became a partner in 2003. He is an ardent SCUBA diver, underwater photographer, and (perhaps because he believes the financial warning that past results do not necessarily predict future performance) roots for the Sharks and the Giants.

*Click on each team member for personal bio*